相关实验视频

Updated: Jun 10, 2025

Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults

Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults

Published on: February 8, 2019

记忆丧失和失误:研究阿尔茨海默氏症和痴呆症患者的跌倒风险

Asmaa Namoos¹, Nicholas Thomson¹, Sarah Bradley¹

¹Department of Surgery, Injury and Violence Prevention Program, School of Medicine, Medical Center West Hospital, Virginia Commonwealth University (VCU), 1200 E Broad Steet, Richmond, VA 23219, USA.

Advances in geriatric medicine and research

|October 18, 2024

概括

患有痴呆症的老年人比患有阿尔茨海默病的人更容易摔倒和创伤性脑损伤 (TBI). 这凸显了痴呆症患者需要专门预防跌倒的需要.

科学领域:

老年学是一门学科.
神经学神经学
公共卫生公共卫生

背景情况:

阿尔茨海默病和痴呆症是老年人的重大健康问题.
这些情况导致老年人中跌倒的发病率很高.
老年人的跌倒可能导致创伤性脑损伤 (TBI).

研究的目的:

调查阿尔茨海默病和痴呆症的老年人中跌倒的发生率和患病率.
探索阿尔茨海默病,痴呆症和结核病发生之间的关联.
为了比较阿尔茨海默病和痴呆症患者之间的跌倒和TBI风险.

主要方法:

对17,000名老年人 (≥65岁) 进行了回顾性队列研究,这些人患有与跌倒有关的伤害.
数据来源于VCUHS (2019-2023) 的TrinetX网络.
分析包括对跌倒,阿尔茨海默病,痴呆症和TBI的描述统计和后勤回归.

主要成果:

患有痴呆症 (12.46%的发病率,17.06%的发病率) 和阿尔茨海默病 (3.11%的发病率,4.81%的发病率) 的老年人有更高的跌倒率.
阿尔茨海默氏病患者患结核病的风险降低 (OR=0.765,p=0.047).
不确定的痴呆症患者患有结核病的风险增加 (OR=1.161,p=0.047).

结论:

与阿尔茨海默病患者相比,患有痴呆症的老年人面临更高的跌倒和TBI风险.
研究结果强调,需要为痴呆症患者制定量身定制的防摔策略.
加强护理人员的教育和支持对于管理与痴呆和跌倒相关的风险至关重要.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.痴呆症痴呆症是一种痴呆症.流行病学流行病学布布布的情况是:年龄较大的成年人.预防预防预防创伤性脑损伤 (TBI) 是一种

更多相关视频

Design and Analysis for Fall Detection System Simplification

Design and Analysis for Fall Detection System Simplification

Published on: April 6, 2020

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

相关概念视频

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...